1. Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson BJDMCNS: A report: the definition and classification of cerebral palsy April 2006. 2007, 109(suppl 109):8–14.
2. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation;Jung EJ,2018
3. Prevalence and lifetime healthcare cost of cerebral palsy in South Korea;Park MS,2011
4. Oskoui M, Coutinho F, Dykeman J, Jette N, Pringsheim TJDM, Neurology C: An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. 2013, 55(6):509–519.
5. Prevalence and demographic characteristics of comorbid epilepsy in children and adolescents with cerebral palsy: a nationwide population-based study;Chiang K-L,2019